Kine Sciences Co., Ltd.
Clinical trials sponsored by Kine Sciences Co., Ltd., explained in plain language.
-
New drug KINE-101 tested for Tough-to-Treat nerve disorder
Disease control CompletedThis early-stage trial tested a single dose of a new drug called KINE-101 in 9 adults with chronic inflammatory demyelinating polyneuropathy (CIDP) that hadn't improved with steroids. The main goal was to check if the drug is safe and tolerable. Researchers also looked at whether…
Phase: PHASE1 • Sponsor: Kine Sciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug KINE-101 tested in humans for first time
Knowledge-focused CompletedThis early-stage trial tested the safety of a new drug called KINE-101 in 40 healthy volunteers. Participants received a single dose either through a vein or under the skin. The main goal was to check for side effects and how the drug moves through the body. No treatment benefit …
Phase: PHASE1 • Sponsor: Kine Sciences Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New drug KINE-101 put to the test in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested the safety of a new drug called KINE-101 in 24 healthy adults. Participants received daily intravenous doses for a week at different strength levels. The goal was to check for side effects and how the drug moves through the body, not to treat any dis…
Phase: PHASE1 • Sponsor: Kine Sciences Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC